Effect of (cid:1) 2 -adrenoceptor agonists and other cAMP-elevating agents on inflammatory gene expression in human ASM cells: a role for protein kinase A

In diseases such as asthma, airway smooth muscle (ASM) cells play a synthetic role by secreting inflammatory mediators such as granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-6, or IL-8 and by expressing surface adhesion molecules, including ICAM-1. In the present study, PGE(2), forskolin, and short-acting (salbutamol) and long-acting (salmeterol and formoterol) beta(2)-adrenoceptor agonists reduced the expression of ICAM-1 and the release of GM-CSF evoked by IL-1beta in ASM cells. IL-1beta-induced IL-8 release was also repressed by PGE(2) and forskolin, whereas the beta(2)-adrenoceptor agonists were ineffective. In each case, repression of these inflammatory indexes was prevented by adenoviral overexpression of PKIalpha, a highly selective PKA inhibitor. These data indicate a PKA-dependent mechanism of repression and suggest that agents that elevate intracellular cAMP, and thereby activate PKA, may have a widespread anti-inflammatory effect in ASM cells. Since ICAM-1 and GM-CSF are highly NF-kappaB-dependent genes, we used an adenoviral-delivered NF-kappaB-dependent luciferase reporter to examine the effects of forskolin and the beta(2)-adrenoceptor agonists on NF-kappaB activation. There was no effect on luciferase activity measured in the presence of forskolin or beta(2)-adrenoceptor agonists. This finding is consistent with the observation that IL-1beta-induced expression of IL-6, a known NF-kappaB-dependent gene in ASM, was also unaffected by beta(2)-adrenoceptor agonists, forskolin, PGE(2), 8-bromo-cAMP, or rolipram. Collectively, these results indicate that repression of IL-1beta-induced ICAM-1 expression and GM-CSF release by cAMP-elevating agents, including beta(2)-adrenoceptor agonists, may not occur through a generic effect on NF-kappaB.

[1]  R. Panettieri,et al.  Mitogenic Effects of Cytokines on Smooth Muscle Are Critically Dependent on Protein Kinase A and Are Unmasked by Steroids and Cyclooxygenase Inhibitors , 2008, Molecular Pharmacology.

[2]  J. Chivers,et al.  Long-Acting β2-Adrenoceptor Agonists Synergistically Enhance Glucocorticoid-Dependent Transcription in Human Airway Epithelial and Smooth Muscle Cells , 2008, Molecular Pharmacology.

[3]  S. Johnston,et al.  Corticosteroids and β2 Agonists Differentially Regulate Rhinovirus-induced Interleukin-6 via Distinct Cis-acting Elements* , 2007, Journal of Biological Chemistry.

[4]  K. Chung,et al.  Validation of the Anti-Inflammatory Properties of Small-Molecule IκB Kinase (IKK)-2 Inhibitors by Comparison with Adenoviral-Mediated Delivery of Dominant-Negative IKK1 and IKK2 in Human Airways Smooth Muscle , 2006, Molecular Pharmacology.

[5]  R. Newton,et al.  Beyond the dogma: novel β2-adrenoceptor signalling in the airways , 2006, European Respiratory Journal.

[6]  S. Johnston,et al.  Combination therapy: Synergistic suppression of virus-induced chemokines in airway epithelial cells. , 2006, American journal of respiratory cell and molecular biology.

[7]  C. Hirshman,et al.  Isoproterenol induces actin depolymerization in human airway smooth muscle cells via activation of an Src kinase and GS. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[8]  M. Yacoub,et al.  Prostanoid receptor expression by human airway smooth muscle cells and regulation of the secretion of granulocyte colony-stimulating factor. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[9]  M. Belvisi,et al.  E-Ring 8-Isoprostanes Are Agonists at EP2- and EP4-Prostanoid Receptors on Human Airway Smooth Muscle Cells and Regulate the Release of Colony-Stimulating Factors by Activating cAMP-Dependent Protein Kinase , 2005, Molecular Pharmacology.

[10]  K. Chung,et al.  Fractalkine/CX3CL1 production by human airway smooth muscle cells: induction by IFN-γ and TNF-α and regulation by TGF-β and corticosteroids , 2004 .

[11]  P. Howarth,et al.  Synthetic responses in airway smooth muscle. , 2004, The Journal of allergy and clinical immunology.

[12]  P. Barnes,et al.  Adenovirus-Mediated Delivery and Expression of a cAMP-Dependent Protein Kinase Inhibitor Gene to BEAS-2B Epithelial Cells Abolishes the Anti-Inflammatory Effects of Rolipram, Salbutamol, and Prostaglandin E2: A Comparison with H-89 , 2004, Journal of Pharmacology and Experimental Therapeutics.

[13]  M. Yacoub,et al.  Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM‐CSF , 2004, British journal of pharmacology.

[14]  R. Panettieri.  Effects of corticosteroids on structural cells in asthma and chronic obstructive pulmonary disease. , 2004, Proceedings of the American Thoracic Society.

[15]  E. Aandahl,et al.  Localized effects of cAMP mediated by distinct routes of protein kinase A. , 2004, Physiological reviews.

[16]  A. Halayko,et al.  Mechanisms of inflammation-mediated airway smooth muscle plasticity and airways remodeling in asthma , 2003, Respiratory Physiology & Neurobiology.

[17]  A. Stewart,et al.  Do inflammatory mediators influence the contribution of airway smooth muscle contraction to airway hyperresponsiveness in asthma? , 2003, Journal of applied physiology.

[18]  J. Lötvall,et al.  Pharmacological modulation of interleukin-17-induced GCP-2-, GRO-alpha- and interleukin-8 release in human bronchial epithelial cells. , 2003, European journal of pharmacology.

[19]  W. Henderson,et al.  Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. , 2003, The Journal of allergy and clinical immunology.

[20]  G. O'Neill,et al.  Tumor Necrosis Factor- α –Induced Secretion of RANTES and Interleukin-6 from Human Airway Smooth Muscle Cells: Modulation by Glucocorticoids and β -Agonists , 2002 .

[21]  M. Yacoub,et al.  RANTES release by human airway smooth muscle: effects of prostaglandin E(2) and fenoterol. , 2001, European journal of pharmacology.

[22]  C. Billington,et al.  Mechanisms of cytokine effects on G protein-coupled receptor-mediated signaling in airway smooth muscle. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[23]  Tak H. Lee,et al.  β2‐Adrenoceptor agonists inhibit release of eosinophil‐activating cytokines from human airway smooth muscle cells , 2001 .

[24]  M. Yacoub,et al.  Effects of Prostaglandin E2 and cAMP Elevating Drugs on GM-CSF Release by Cultured Human Airway Smooth Muscle Cells , 2001 .

[25]  M. Yacoub,et al.  Effects of prostaglandin E2 and cAMP elevating drugs on GM-CSF release by cultured human airway smooth muscle cells. Relevance to asthma therapy. , 2001, American journal of respiratory cell and molecular biology.

[26]  A. Ammit,et al.  Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth-muscle cells. Modulation by cyclic adenosine monophosphate. , 2000, American journal of respiratory cell and molecular biology.

[27]  R. Ye.  β-Adrenergic agonists regulate NF-κB activation through multiple mechanisms , 2000 .

[28]  P. Howarth,et al.  The effect of long-acting beta2-agonists on airway inflammation in asthmatic patients. , 2000, Respiratory medicine.

[29]  J. Martin,et al.  The contribution of airway smooth muscle to airway narrowing and airway hyperresponsiveness in disease. , 2000, The European respiratory journal.

[30]  A. Ammit,et al.  Tumor Necrosis Factor-a – Induced Secretion of RANTES and Interleukin-6 from Human Airway Smooth-Muscle Cells Modulation by Cyclic Adenosine Monophosphate , 2000 .

[31]  P. Cohen,et al.  Specificity and mechanism of action of some commonly used protein kinase inhibitors. , 2000, The Biochemical journal.

[32]  R. Panettieri,et al.  Dexamethasone Pathway That Is Only Partially Sensitive to B-dependent Signaling Κ Involves an Nf- Human Tracheal Smooth Muscle Cells Up-regulation of Icam-1 by Cytokines In , 2013 .

[33]  P. Howarth,et al.  The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma. , 1999, The European respiratory journal.

[34]  J. Benovic,et al.  Pharmacological inhibition of protein kinases in intact cells: antagonism of beta adrenergic receptor ligand binding by H-89 reveals limitations of usefulness. , 1999, The Journal of pharmacology and experimental therapeutics.

[35]  T. Lee,et al.  Cultured human airway smooth muscle cells stimulated by interleukin-1beta enhance eosinophil survival. , 1998, American journal of respiratory cell and molecular biology.

[36]  M. Yacoub,et al.  Expression of cyclo‐oxygenase‐2 in human airway smooth muscle is associated with profound reductions in cell growth , 1998, British journal of pharmacology.

[37]  P. Barnes,et al.  Pharmacology of airway smooth muscle. , 1998, American journal of respiratory and critical care medicine.

[38]  A. Knox,et al.  Bradykinin stimulates IL-8 production in cultured human airway smooth muscle cells: role of cyclooxygenase products. , 1998, Journal of immunology.

[39]  K. Chung,et al.  Expression and release of interleukin-8 by human airway smooth muscle cells: inhibition by Th-2 cytokines and corticosteroids. , 1998, American journal of respiratory cell and molecular biology.

[40]  A. Knox,et al.  Effect of interleukin‐1β, tumour necrosis factor‐α and interferon‐γ on the induction of cyclo‐oxygenase‐2 in cultured human airway smooth muscle cells , 1997 .

[41]  M. Yacoub,et al.  Release of granulocyte‐macrophage colony stimulating factor by human cultured airway smooth muscle cells: suppression by dexamethasone , 1997, British journal of pharmacology.

[42]  M. Yacoub,et al.  Induction of cyclo‐oxygenase‐2 by cytokines in human cultured airway smooth muscle cells: novel inflammatory role of this cell type , 1997, British journal of pharmacology.

[43]  Anders Lindén.  Increased interleukin‐8 release by β‐adrenoceptor activation in human transformed bronchial epithelial cells , 1996, British journal of pharmacology.

[44]  E. Puré,et al.  Activation of cAMP-dependent pathways in human airway smooth muscle cells inhibits TNF-alpha-induced ICAM-1 and VCAM-1 expression and T lymphocyte adhesion. , 1995, Journal of immunology.

[45]  T. Torphy,et al.  Beta-adrenoceptors, cAMP and airway smooth muscle relaxation: challenges to the dogma. , 1994, Trends in pharmacological sciences.